centers gradually changed from cyclosporine to tacrolimus and from azathioprine to mycophenolate as first-line maintenance immunosuppressive treatment. 4 Mammalian target of rapamycin (mTOR) inhibitors are not part of the standard regimen in Denmark, but may be used when withdrawal of calcineurin inhibitors is desirable. 4 As survival after renal transplantation has increased considerably over the past decades, 5, 6 it is increasingly important to focus on the potential risk of complications due to immunosuppressive treatment in RTRs.
Genital warts (GWs) are anogenital lesions caused by infection with the sexually transmitted human papillomavirus (HPV), mainly the nononcogenic HPV types 6 and 11. 7 GWs are common in the general population. In 2 large surveys conducted in 2004 and 2007 among Scandinavian men and women aged 18-45 years, 11% of women and 8% of men reported having had GWs. 8, 9 Although the GW incidence has declined considerably in birth cohorts with high coverage of quadrivalent HPV vaccination, the incidence remains high in unvaccinated populations where herd protection is not present. 10 GWs are associated with negative psychological and social consequences, including feelings of shame, depression, fear, and reduced quality of life. 11, 12 Furthermore, a large Danish register study found that women and men with GWs are at increased risk of subsequent HPV-related cancers.
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Due to the immunosuppressive treatment in RTRs, it is likely that these patients are at increased risk of GWs, because of increased risk of incident HPV infections or reactivation of latent HPV. Large, population-based cohort studies have found that RTRs have a higher incidence than the general population of cancers associated with oncogenic HPV types, including cervical, vaginal, vulvar, anal, penile, and some oropharyngeal cancers. [14] [15] [16] [17] [18] [19] [20] [21] Furthermore, RTRs are at high risk of viral cutaneous warts. [22] [23] [24] However, only a few studies have investigated the prevalence or incidence of GWs in RTRs [25] [26] [27] [28] or solid organ transplant recipients in general, 29, 30 and none of these studies were population based. The previous studies were limited by crosssectional design 26, 27, 29 ; small patient populations (<150 RTRs) [25] [26] [27] ; <20 GW cases [25] [26] [27] [28] [29] ; and/or lack of an immunocompetent control group. 25, 26, [28] [29] [30] In this population-based, prospective cohort study, we used nationwide Danish registers to investigate the risk of GWs in RTRs compared with a cohort of nonrenal transplant recipients (non-RTRs).
| MATERIAL S AND ME THODS

| Design and data sources
This study is a historical, prospective cohort study based on the data from Danish registers. Register linkage was accomplished using each individual's unique personal identification number, which is assigned to all Danish residents and is used in all health and administrative registers. 31 The study was approved by the Danish Data Protection
Agency (reference number 2015-41-3740). 
| Study population
| Other variables
Educational level and income in the year before baseline were defined using data from Statistics Denmark. 35 Education was categorized as low (mandatory school only, corresponding to 7-9 years of schooling); medium (secondary school and vocational education, ≈10-12 years of schooling); or higher (short, medium-, or long-term higher education, >12 years of schooling). Income was defined as the annual disposable income in the year before baseline and was divided into tertiles in each income year. 
| Statistical analyses
Initially, we used the Aalen-Johansen estimator to estimate the cumula- All adjustment variables were selected a priori based on a hypothesis that they could potentially confound the association between renal transplantation and GW risk. Information on education and income was missing for 9% and 5%, respectively, of the study population.
These individuals were retained in the regression model in the main analysis, but when they were omitted in a sensitivity analysis, our conclusions were unchanged. The regression analyses were initially conducted for both sexes combined, but we also fit separate models
for men and women and tested for effect modification by sex. The proportional hazards assumption was checked using Schoenfield residuals, which indicated that the effect of renal transplantation on GW risk differed by age. Therefore, we subsequently estimated separate HRs for individuals aged <30 and ≥30 years.
In an additional analysis, we estimated the HR of GWs in RTRs 
| RE SULTS
| Participants
A total of 3279 first-time RTRs in the period 1996 to 2015 were identified in the Danish Nephrology Registry, and 163 950 matched nonRTRs were selected from the Civil Registration System. We excluded 11 RTRs (and their corresponding non-RTRs) with GWs within 1 year before baseline. An additional 490 non-RTRs with GWs within 1 year before baseline were also excluded. Thus, the final study population consisted of 3268 RTRs and 162 910 non-RTRs. Table 1 shows baseline characteristics of the study population.
The majority (62.5%) of the RTRs were males and most (66.3%)
were ≥40 years at transplantation. The most common cause of 
| Cumulative incidence of GWs
The RTRs contributed 23 926 person-years at risk during follow-up, whereas non-RTRs contributed 1 377 972 person-years.
A total of 132 RTRs and 2025 non-RTRs experienced GWs. Figure 1 shows the cumulative incidence of GWs in RTRs and non-RTRs as a function of time since baseline, stratified by age at baseline and sex. In both RTRs and non-RTRs, the cumulative GW incidence was highest in the younger age groups and lowest in those aged ≥40 years at baseline. In all age groups and for both men and women, RTRs had higher cumulative incidence of GWs than non-RTRs. In RTRs, the cumulative GW incidence generally increased sharply in the years following transplantation, whereas the cumulative incidence in non-RTRs increased more steadily and slowly. The difference in cumulative incidence between RTRs and non-RTRs was more pronounced in women than in men, except in individuals aged ≥40 years at baseline where the cumulative incidences were similar in men and women.
The highest cumulative incidences of GWs were seen in female
RTRs aged ≤19 and 20-29 years at baseline, of whom >15% and 20%, respectively, had experienced GWs within 15 years after transplantation. 
| HR of GWs
| HR of GWs during periods of functioning graft and dialysis after graft failure
A total of 593 RTRs (18.1%) underwent dialysis after graft failure at least once during follow-up. Table 3 shows the HR of GWs in RTRs compared with non-RTRs, under periods of functioning graft and periods of dialysis after graft failure. In both men and women, the HR of GWs tended to be higher during periods of functioning graft than during periods of dialysis, although the differences in estimates were not statistically significant. Furthermore, RTRs had higher hazard of GWs than non-RTRs irrespective of year of transplantation. When looking at age at transplantation, the hazard in RTRs compared with non-RTRs was increased in all age groups, but the HR estimates tended to be more pronounced in RTRs transplanted at an older age (age at transplantation ≥30 years) than in those transplanted earlier in life (age at transplantation <30 years).
| HR of GWs by transplantation-related characteristics
| D ISCUSS I ON
In this prospective cohort study of 3268 RTRs and 162 910 nonRTRs, we found that RTRs had a >3-fold higher risk of GWs than non-RTRs, after adjusting for age and sex, and the risk was almost 5-fold increased for female RTRs compared with non-RTRs.
The risk of GWs in RTRs was increased already in the first year after transplantation and remained increased throughout followup (≥10 years). In both RTRs and non-RTRs, the cumulative incidence of GWs was highest in the younger age groups and lowest in those aged ≥40 years at baseline, but the cumulative incidence was higher in RTRs than in non-RTRs in all age groups and in both men and women.
Immunosuppression is presumed to increase the risk of HPVrelated disease, including GWs among RTRs. 39 However, the few previous studies of GWs in RTRs were based on small patient populations from specific clinical settings 25-30 and most did not include an immunocompetent control group. 25, 26, [28] [29] [30] To our knowledge, this is the first nationwide study to examine the risk of GWs in RTRs compared with a population-based sample of non-RTRs, and to confirm that RTRs have an elevated risk of GWs.
Our finding of an increased risk of GWs in RTRs compared with non-RTRs is in accordance with several population-based cohort studies that have found an increased incidence of HPV-related anogenital malignancies in RTRs compared with the general population. [14] [15] [16] [17] [18] [19] [20] [21] In addition, smaller cross-sectional studies have shown that RTRs have a high prevalence of viral cutaneous warts caused by HPV infection, with warts being significantly more common in RTRs who had been transplanted for a longer time. 22, 23 RTRs are also at increased risk of other cancers caused by viral infections such as Hodgkin lymphoma, 16, 20 variants of non-Hodgkin lymphoma caused by Epstein-Barr virus, and
Kaposi sarcoma caused by human herpes virus-8, 16, 17, 20, 40 which is believed to be related to impaired T cell response to these viruses caused by the immunosuppressive treatment. 41 In the age-stratified analysis, we found that the increased risk of GWs in RTRs relative to non-RTRs was more pronounced in older individuals (aged ≥30 years). However, in absolute terms, the cumulative incidence of GWs was highest among young RTRs aged <30 years ( Figure 1 ). This finding is in accordance with the observation that the HPV prevalence in the general population is highest in younger age groups, 42, 43 and therefore the GW incidence is also highest among younger men and women. 10 In the daily clinical setting, this means that the clinician should be especially aware of GWs among young RTRs aged <30 years. However, in countries such as Denmark, where quadrivalent or nonavalent HPV vaccination is implemented, this age pattern will likely change during the coming decades, because an increasing proportion of young, female RTRs will have been vaccinated against HPV 6 and HPV 11 during adolescence, and their male counterparts from the same birth cohorts will increasingly be covered by herd protection. 10 This will likely lead to a decline in the GW incidence in younger birth cohorts. 44 An additional finding in our study was that the risk of GWs in
RTRs compared with non-RTRs tended to be higher during periods of functioning graft than during periods of dialysis after graft failure. Although not statistically significant in our study, this finding is in accordance with an Australian registry-based study 17 where the incidences of HPV-associated cancers (anogenital, oral cavity, and TA B L E 3 Hazard ratio of genital warts in Danish renal transplant recipients (RTRs) 1996-2015 vs a nontransplanted control cohort (non-RTRs), under periods of functioning graft and periods of dialysis after graft failure, respectively, stratified by sex RTRs compared with the general population were higher after transplantation than during periods of dialysis before transplantation. 19 These findings support the hypothesis that the driving mechanism of the increased risk for HPV-related diseases among RTRs is the immunosuppressive treatment received during periods of functioning graft.
The strengths of this study include the population-based design, the large sample, and the comprehensive information obtained from nationwide registries with high validity and virtually complete coverage. Using registries, we were able to identify GW episodes treated in both hospitals and general practice all over Denmark, thus allowing a more complete outcome determination than studies relying on, eg, self-report or patient files from a single clinic. Furthermore, unlike previous studies of HPV-related malignancies in RTRs, [14] [15] [16] [17] [18] [19] [20] [21] we were able to adjust for several other variables that could potentially influence the risk of GWs, including socioeconomic status, HPV vaccination, and other potential causes of immunosuppression (HIV/AIDS and other solid organ transplantations). However, the study also has some limitations. found that the incidence rate of cervical smears was only slightly increased in female RTRs compared with non-RTRs. Therefore, we believe it is unlikely that the increased GW risk observed in RTRs is completely explained by surveillance bias.
In conclusion, in the present study both male and female RTRs had an increased risk of GWs shortly after transplantation that remained elevated for ≥10 years. This supports the hypothesis that RTRs are a high-risk group for HPV-related diseases, including not only GWs, but also HPV-related precancerous lesions and cancers. 13 Implementation of a yearly cervical smear among female RTRs in Danish national guidelines should be considered, as is currently recommended by European expert guidelines, 46 mainly to find cervical precancerous lesions and cancer, but also as an opportunity for a pelvic examination to find other anogenital 
TA B L E 4
Hazard ratio of genital warts in Danish renal transplant recipients (RTRs) 1996-2015 vs a nontransplanted control cohort (non-RTRs), according to transplantation-related characteristics precancerous lesions or cancer and GWs. Furthermore, a yearly anogenital examination could also be considered for male RTRs, including inspection of the penile skin and foreskin, the scrotum, perineal and perianal area. Special attention should be paid to the young RTRs as they are at highest risk of developing GWs. In future studies, it would be interesting to evaluate the risk of HPV-related disease in RTRs, depending on the immunosuppressive treatment regimen, eg, calcineurin inhibitors vs mTOR-based regimens. In addition, studies are needed to evaluate whether HPV vaccination including protection against HPV types 6 and 11 should be offered to end-stage renal disease patients prior to transplantation, and if so, which age groups should be targeted.
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